Newsbenzinga
Seaport Therapeutics To Present Phase 1 Clinical Data For GlyphAgo At The European College Of Neuropsychopharmacology Congress, October 10-13
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…